- SPACs
- Achari Ventures Holdings Corp. I
Achari Ventures Holdings Corp. I
Completed 2024-09-06- CIK 1844507
- AVHI
- IPO 2021-10-18
- $6.3M trust
- 154 filings
Successfully merged with Vaso Corporation
- IPO Size
- $100M
- raised at the IPO
- Trust
- $6.3M
- as of 2024-06-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
154 filings over 16 quarters; violet bars carry a milestone
- 21 Q1: 2 filings
- 21 Q2: 3 filings
- 21 Q3: 5 filings
- 21 Q4: 23 filings
- 22 Q1: 6 filings
- 22 Q2: 3 filings
- 22 Q3: 1 filing
- 22 Q4: 9 filings
- 23 Q1: 8 filings
- 23 Q2: 12 filings
- 23 Q3: 9 filings
- 23 Q4: 13 filings
- 24 Q1: 9 filings
- 24 Q2: 19 filings
- 24 Q3: 30 filings
- 24 Q4: 2 filings
- S-1 filed 21 Q1
- IPO 21 Q4
- Definitive agreement 23 Q4
- Completed 24 Q3
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2021-02-26 Filed S1
- IPO2021-10-18 IPO, search begins
- Definitive Agreement2023-12-06 Agreement for merger
- Completed2024-09-06 Merger Completed
About
Achari Ventures Holdings Corp. I is a blank-check company seeking an initial business combination, with an initial focus on acquisition opportunities in the cannabis industry, particularly ancillary (non-plant touching) cannabis businesses. It excludes targets it determines have operated in violation of U.S. federal law.
Investment Focus
Cannabis
Key Information
As the filings state it
- IPO Date
- 2021-10-18
- Total Redemptions
- $103M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2024-09-06
- Merger Target
- Vaso Corporation
- SPAC Ticker
- AVHI
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team includes investment, operating, marketing, legal and regulatory experience, with over 30 years of traditional investment experience, over 28 years of M&A experience and cannabis operating and investing experience. Its members include Vikas Desai, Merrick Friedman, Mitchell Hara and independent directors with corporate, investing and cannabis-sector backgrounds.